Cancer therapy tested at UNC gets closer to approval
Friday, July 14, 2017
Advisors to the Food and Drug Administration on Wednesday unanimously recommended approval for a new cancer therapy, which was shown to be successful in trials at the UNC Lineberger Comprehensive Cancer Center. The treatment, being developed by Novartis, would be the first to use a patient's own immune cells to attack invading cancer cells. (WRAL.com)
Related: Campus Connections
Share: Facebook | Twitter | Email
Recent Campus Connections News:
John Skipper Details His ESPN Exit and an Extortion PlotHorace Williams Airport may shut down. Here's a history of its impact at UNC.
Thursday March 15, 2018
Wednesday March 14, 2018A ‘symbol of the life of the University’
Tuesday March 13, 2018Legend of castle and bloody boulder has long entranced UNC students. But how true is it?
Monday March 12, 2018Anne Cates, first female UNC trustees chair: ‘After 200 years, I was it’
Monday March 12, 2018UNC study could help parents predict childhood autism at early age
Sunday March 11, 2018